For past Congresses, use the Browse menu.
HR 6062
116th Congress • 2019–2021 (Ended)

To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…